Estimation of pharmacokinetic parameters of digoxin from serum, saliva and urine. 1978

H Allonen, and E Iisalo, and L Kangas, and R Lammintausta, and M Salonen

The pharmacokinetics of digoxin was studied in 14 healthy volunteers using concentrations measured radioimmunologically in the serum, saliva and urine. The subjects were given 0.75 mg of digoxin intravenously. Serum and saliva were obtained over a 72 hr period and urinary excretion rates over 6 or 7 days. Binding of digoxin to serum proteins was determined by ultracentrifugalization. A linear correlation between the serum and saliva concentrations was found. Salivary levels were equal to the unbound fraction in the serum. The half-lives of distribution did not differ between the serum and saliva. An erroneously short half-life of elimination was found in the serum, but in the saliva and urine it was found to be in the range previously reported. Salivary level measurements may be useful in pharmacokinetic studies and may have important clinical implications.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012463 Saliva The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin. Salivas

Related Publications

H Allonen, and E Iisalo, and L Kangas, and R Lammintausta, and M Salonen
September 1974, Clinical pharmacology and therapeutics,
H Allonen, and E Iisalo, and L Kangas, and R Lammintausta, and M Salonen
January 1975, Research communications in chemical pathology and pharmacology,
H Allonen, and E Iisalo, and L Kangas, and R Lammintausta, and M Salonen
January 1995, Proceedings. Symposium on Computer Applications in Medical Care,
H Allonen, and E Iisalo, and L Kangas, and R Lammintausta, and M Salonen
March 1975, Clinical pharmacology and therapeutics,
H Allonen, and E Iisalo, and L Kangas, and R Lammintausta, and M Salonen
October 1978, Polski tygodnik lekarski (Warsaw, Poland : 1960),
H Allonen, and E Iisalo, and L Kangas, and R Lammintausta, and M Salonen
July 1975, Annals of clinical biochemistry,
H Allonen, and E Iisalo, and L Kangas, and R Lammintausta, and M Salonen
January 1988, Therapeutic drug monitoring,
H Allonen, and E Iisalo, and L Kangas, and R Lammintausta, and M Salonen
May 1977, Klinische Wochenschrift,
H Allonen, and E Iisalo, and L Kangas, and R Lammintausta, and M Salonen
January 1984, Farmakologiia i toksikologiia,
H Allonen, and E Iisalo, and L Kangas, and R Lammintausta, and M Salonen
August 1978, Lijecnicki vjesnik,
Copied contents to your clipboard!